Dexcom (DXCM) Price to Sales (2010 - 2026)

Dexcom (DXCM) has reported Price to Sales for 17 consecutive years, with 19.43 the latest figure, recorded in Q2 2026.

• On a quarterly basis, Price to Sales fell 34.34% year-over-year to 19.43 in Q2 2026; TTM through Jun 2026 was 5.12, a 35.74% decrease from a year earlier, with the FY2025 full-year figure at 5.48, down 27.29% from the prior year.
• Price to Sales was 19.43 for Q2 2026 at Dexcom, down from 20.33 in the prior quarter.
• Over five years, Price to Sales peaked at 79.82 in Q1 2022 and troughed at 19.43 in Q2 2026.
• A 5-year average of 39.58 and a median of 38.7 in 2022 frame the typical range for Price to Sales.
• Across the five-year window, Price to Sales surged 35.49% in 2023 and slumped 56.67% in 2025, its largest moves.
• Over 5 years, Price to Sales stood at 53.66 in 2022, then retreated by 13.85% to 46.23 in 2023, then tumbled by 40.97% to 27.29 in 2024, then decreased by 25.7% to 20.28 in 2025, then declined by 4.19% to 19.43 in 2026.
• The last three Price to Sales figures came in at 19.43 (Q2 2026), 20.33 (Q1 2026), and 20.28 (Q4 2025), per Business Quant data.